ir.apricusbio.com ir.apricusbio.com

ir.apricusbio.com

Investor Home | Investors | Apricus Biosciences

Mission / Vision / Values. Annual Meeting of Stockholders. Apricus Biosciences, Inc. at the Canaccord Genuity 35th Annual Growth Conference. 160;at 10:00 am ET. Apricus Biosciences, Inc. at the Canaccord Genuity 35th Annual Growth Conference. Wednesday, August 12, 2015 . 10:00 am ET  . Click here for webcast. Click here to add this event to your calendar. Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Twelve Additional Countries. RayVa Phase 2a Trial Top...

http://ir.apricusbio.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.APRICUSBIO.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

October

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.6 out of 5 with 7 reviews
5 star
4
4 star
3
3 star
0
2 star
0
1 star
0

Hey there! Start your review of ir.apricusbio.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

3.5 seconds

CONTACTS AT IR.APRICUSBIO.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investor Home | Investors | Apricus Biosciences | ir.apricusbio.com Reviews
<META>
DESCRIPTION
Mission / Vision / Values. Annual Meeting of Stockholders. Apricus Biosciences, Inc. at the Canaccord Genuity 35th Annual Growth Conference. 160;at 10:00 am ET. Apricus Biosciences, Inc. at the Canaccord Genuity 35th Annual Growth Conference. Wednesday, August 12, 2015 . 10:00 am ET  . Click here for webcast. Click here to add this event to your calendar. Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Twelve Additional Countries. RayVa Phase 2a Trial Top...
<META>
KEYWORDS
1 news
2 careers
3 about apricus
4 management
5 board of directors
6 pipeline
7 vitaros
8 fispemifene
9 rayva
10 business development
CONTENT
Page content here
KEYWORDS ON
PAGE
news,careers,about apricus,management,board of directors,pipeline,vitaros,fispemifene,rayva,business development,resources,investor relations,stock information,news and events,financials,corporate governance,shareholder services,investor home,webcast,date
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investor Home | Investors | Apricus Biosciences | ir.apricusbio.com Reviews

https://ir.apricusbio.com

Mission / Vision / Values. Annual Meeting of Stockholders. Apricus Biosciences, Inc. at the Canaccord Genuity 35th Annual Growth Conference. 160;at 10:00 am ET. Apricus Biosciences, Inc. at the Canaccord Genuity 35th Annual Growth Conference. Wednesday, August 12, 2015 . 10:00 am ET  . Click here for webcast. Click here to add this event to your calendar. Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Twelve Additional Countries. RayVa Phase 2a Trial Top...

INTERNAL PAGES

ir.apricusbio.com ir.apricusbio.com
1

Process Calendar

http://ir.apricusbio.com/ProcessCalendarRequest.asp?eventId=5200660&OverridePage=irol-EventDetails&checkJS=false

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

1

LINKS TO THIS WEBSITE

apricusbio.com apricusbio.com

Pipeline | Apricus Biosciences

http://www.apricusbio.com/pipeline

Mission / Vision / Values. News & Events. Marketed in Europe Approved in Canada Development Stage in the U.S. It is estimated that, worldwide, 150 million men suffer with erectile dysfunction. Factors contributing to the appearance of the disease or its severity include medical history, tobacco use and age. Erectile dysfunction is also found in men with cardiovascular disease. Click to Read More. Click to Read More. Click to Read More. Apricus Biosciences, Inc. NexMed (U.S.A.), Inc. San Diego, CA 92130.

apricusbio.com apricusbio.com

About Apricus | Apricus Biosciences

http://www.apricusbio.com/about-apricus

Mission / Vision / Values. News & Events. WE ARE COMMITTED TO THE CONTINUED DEVELOPMENT AND COMMERCIALIZATION OF NOVEL THERAPIES ADDRESSING UNMET MEDICAL NEEDS. Its product candidate for the treatment of the circulatory disorder Raynaud’s phenomenon, and plans to conduct additional clinical trials in patients with Raynaud’s phenomenon secondary to scleroderma. Apricus’ lead commercial product, Vitaros. Apricus Biosciences, Inc. NexMed (U.S.A.), Inc. 11975 El Camino Real, Suite 300. San Diego, CA 92130.

apricusbio.com apricusbio.com

Management | Apricus Biosciences

http://www.apricusbio.com/about-apricus/management

Mission / Vision / Values. News & Events. Our experienced leadership team is strategically aligned to provide significant value to each of our core business initiatives. Richard W. Pascoe has been a director and served as our Chief Executive Officer since March 2013 and has served as the Company’s Secretary since February 2015. Senior Vice President, Chief Development Officer. Brian T. Dorsey has been our Senior Vice President, Chief Development Officer since December 2014. Mr Morton received his M.B...

apricusbio.com apricusbio.com

Business Development | Apricus Biosciences

http://www.apricusbio.com/business-development

Mission / Vision / Values. News & Events. We partner with established and successful commercial pharmaceutical companies who are committed to providing life-improving treatments to patients. Vitaros is partnered in many countries globally with world class companies. RayVa or alprostadil topical cream is being developed to treat the symptoms associated with Raynaud Phenomenon secondary to systemic sclerosis. When partnering, we ensure that our partners share our vision for our products. Each partner h...

apricusbio.com apricusbio.com

Fispemifene | Apricus Biosciences

http://www.apricusbio.com/pipeline/fispemifene

Mission / Vision / Values. News & Events. Fispemifene is a once daily orally administered selective estrogen receptor modulator (SERM) in development for multiple urological conditions in men. A Phase 2 clinical trial is expected to commence during the first half of 2015 to confirm the optimal fispemifene doses to treat men with secondary hypogonadism, and provide proof-of-concept data to evaluate the the relief of symptoms associated with this condition. Apricus Biosciences, Inc. San Diego, CA 92130.

apricusbio.com apricusbio.com

Vitaros® | Apricus Biosciences

http://www.apricusbio.com/pipeline/vitaros

Mission / Vision / Values. News & Events. Our product, Vitaros. Is a topical cream for the treatment of erectile dysfunction. Vitaros. Is locally applied and contains alprostadil plus our novel excipient. Vitaros. Is approved in Europe and Canada and currently marketed in Europe. TARGETING THE UNTREATED ERECTILE DYSFUNCTION MARKET. Whereas phosphodiesterase inhibitors are taken in the form of a tablet, Vitaros. Because men with erectile dysfunction often have other diseases, Vitaros. Was also evaluated i...

apricusbio.com apricusbio.com

Mission / Vision / Values | Apricus Biosciences

http://www.apricusbio.com/about-apricus/mission-vision-values

Mission / Vision / Values. News & Events. Mission / Vision / Values. Mission / Vision / Values. Our vision is to be a leader in the development and commercialization of innovative products that provide life-improving treatments to patients. Drive, Dedication, Passion, Respect and Integrity. Apricus Biosciences, Inc. NexMed (U.S.A.), Inc. 11975 El Camino Real, Suite 300. San Diego, CA 92130. Mission / Vision / Values. News & Events. Apricus Biosciences, Inc. 2016. Privacy Policy and Safe Harbor.

apricusbio.com apricusbio.com

RayVa™ | Apricus Biosciences

http://www.apricusbio.com/pipeline/rayva

Mission / Vision / Values. News & Events. RayVa or alprostadil topical cream is being developed to treat the symptoms associated with Raynaud's Phenomenon secondary to systemic sclerosis. The active pharmaceutical ingredient in RayVa is alprostadil and, with DDAIP.HCl, allows local delivery of the vasodilator to the site of action. What is Raynaud’s phenomenon? First described in the 1800’s, it is the transient loss of blood flow to the extremities, however, the primary cause remains unexplained.

apricusbio.com apricusbio.com

Careers | Apricus Biosciences

http://www.apricusbio.com/careers

Mission / Vision / Values. News & Events. Apricus is a pharmaceutical company located in the greater San Diego, California area that offers outstanding opportunities in pharmaceutical development. Apricus Biosciences, Inc. employs a best-in-class group of professionals with the skills and expertise to operate our business successfully. We recognize that a pleasant and productive work environment is an important aspect of our culture and we celebrate individual and company-wide performance.

UPGRADE TO PREMIUM TO VIEW 17 MORE

TOTAL LINKS TO THIS WEBSITE

26

OTHER SITES

ir.apolloresidentialmortgage.com ir.apolloresidentialmortgage.com

APOLLORESIDENTIALMORTGAGE.COM

Drip and Direct Stock Purchase Plan. Q2 2015 Apollo Residential Mortgage Earnings Conference Call. 160;at 11:00 am ET. Q2 2015 Apollo Residential Mortgage Earnings Conference Call. Thursday, August 6, 2015 . 11:00 am ET  . Click here for webcast. Click here to add this event to your calendar. 160; 0.1. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. Mergers and Acquisition Announcement. Apollo Residential Mortgage, Inc. Reports Second Quarter 2015 Financial Results. NEW YORK- (BUSINESS WIRE)- Au...

ir.appfolioinc.com ir.appfolioinc.com

Investor Overview | AppFolio, Inc.

We create easy-to-use, cloud-based software that helps small and mid-sized businesses more effectively market, manage and grow their business. Today, our products serve the legal and property management industries. 160;  0.35. AppFolio, Inc. Announces Second Quarter 2015 Financial Results. AppFolio, Inc. Announces Date of Second Quarter 2015 Financial Results Release. AppFolio, Inc. Announces Exercise and Closing of Over-Allotment Option for Initial Public Offering. There are currently no events scheduled.

ir.applehospitalityreit.com ir.applehospitalityreit.com

Corporate Overview - Apple Hospitality Reit

RESIDENCE INN, BURBANK, CALIFORNIA. Apple Hospitality REIT, Inc. (NYSE: APLE) owns one of the largest portfolios of upscale, select service hotels in the United States. Our national, geographically diverse portfolio consists of 235 Hilton. Branded hotels located across 33 states, serving some of the country’s top markets for business and leisure travelers. And our hotels operate exclusively under some of the nation’s leading brands: Courtyard by Marriott. Fairfield Inn by Marriott. Hampton Inn by Hilton.

ir.applied.com ir.applied.com

Investor Relations Home | Applied Industrial Technologies | Applied.com

Applied Industrial Technologies is a leading North American distributor of industrial products and services. Why Invest in Applied? E-mail the Board of Directors. Q4 2015 Applied Industrial Technologies Earnings Conference Call. 160;at 10:00 am ET. Q4 2015 Applied Industrial Technologies Earnings Conference Call. Wednesday, August 12, 2015 . 10:00 am ET  . Click here for webcast. Click here to add this event to your calendar. 160; 0.23. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. CLEVELAND, ...

ir.approachresources.com ir.approachresources.com

Approach Resources - Investors

Approach Resources Inc. (NASDAQ: AREX) is an independent oil and gas company headquartered in Fort Worth, Texas. Our operations are focused on exploration, development, production and acquisition of oil and gas properties. We own a leading position in the southern Midland Basin of the greater Permian Basin in West Texas, where we are developing the horizontal Wolfcamp shale oil play. Approach Resources Inc. Reports Second Quarter 2015 Results. View All News Releases. Abundant, Low-cost drilling targets.

ir.apricusbio.com ir.apricusbio.com

Investor Home | Investors | Apricus Biosciences

Mission / Vision / Values. Annual Meeting of Stockholders. Apricus Biosciences, Inc. at the Canaccord Genuity 35th Annual Growth Conference. 160;at 10:00 am ET. Apricus Biosciences, Inc. at the Canaccord Genuity 35th Annual Growth Conference. Wednesday, August 12, 2015 . 10:00 am ET  . Click here for webcast. Click here to add this event to your calendar. Apricus Biosciences Announces Approval of Vitaros(R) for the Treatment of Erectile Dysfunction in Twelve Additional Countries. RayVa Phase 2a Trial Top...

ir.aptevotherapeutics.com ir.aptevotherapeutics.com

Investor Home : Investors : Aptevo

Aptevo Therapeutics and the ADAPTIR (Modular Protein Technology) Platform: The Future of Immuno-oncology. 160;  0.08 (3.21%). Updated January 13, 2017  4:00 pm ET. Stacey L. Jurchison. Senior Director, Investor Relations and Corporate Communications. Aptevo Therapeutics Inc at 29th Annual ROTH Conference. Aptevo Therapeutics Inc at the 16th Annual PEPTALK Conference. Aptevo Therapeutics Inc at Piper Jaffray 28th Annual Healthcare Conference.

ir.aptg.com.tw ir.aptg.com.tw

A+ Asia Pacific Telecom Website

ir.aptose.com ir.aptose.com

Aptose Biosciences - Investors - Overview

SELECT SOLID TUMOR INDICATIONS. CDX2 AND KRUPPEL-LIKE FACTOR BIOLOGY. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. January 10, 2017. 160;at 9:00 am PT. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. Tuesday, January 10, 2017 . 9:00 am PT  . Click here for webcast. Click here to add this event to your calendar. January 5, 2017. Aptose Biosciences to Present at Biotech Showcase 2017 Conference. December 29, 2016. Aptose Biosciences Provides Update on APTO-253 Development.

ir.aqr.com ir.aqr.com

AQR Capital - Investor Relations - Overview

Investor and Media Contact. There are currently no news releases. Primary IR and Media Contact. Quotes delayed at least 15 minutes. Market data provided by Interactive Data. Powered and implemented by Interactive Data Managed Solutions.

ir.aquaamerica.com ir.aquaamerica.com

Investor Relations | Aqua America

Skip to main navigation. Reconciliation of GAAP to Non-GAAP Financial Measures. Regulated segment - Efficiency ratio adjusted for purchased water. Reconciliation of GAAP to Non-GAAP financial measures - EBITDA reconciliation for continuing operations. Adjusted Net Income EPS Q4 2017. Dividend Reinvestment and DSPP. There are currently no events to display. Feb 27, 2018. Aqua America Reports Earnings for 2017, Announces 2018 Guidance. Feb 5, 2018. Aqua America Declares March 2018 Dividend. Feb 1, 2018.